Epithelial V-Like Antigen Mediates Efficacy of Anti-Alpha4 Integrin Treatment in a Mouse Model of Multiple Sclerosis

Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica

(2012) Ingo Kleiter   ARCHIVES OF NEUROLOGY

Current Immunotherapy of Multiple Sclerosis and Future Challenges: Relevance of Immune-Mediated Repair

(2012) Michael D. Carrithers   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis

(2012) Luca Prosperini et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

(2012) Gary Bloomgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antigen-specific memory in B-1a and its relationship to natural immunity

(2012) Y. Yang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Multiple Regulatory Mechanisms Control B-1 B Cell Activation

(2012) Vishal J. Sindhava et al.   Frontiers in Immunology

Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis

(2011) Raquel Planas et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Characterization of epithelial V-like antigen in human choroid plexus epithelial cells: Potential role in CNS immune surveillance

(2011) Elise Wojcik et al.   NEUROSCIENCE LETTERS

Interferon Beta Treatment in Neuromyelitis Optica

(2010) Jacqueline Palace et al.   ARCHIVES OF NEUROLOGY

B cells expressing CD5 are increased in cerebrospinal fluidof patients with multiple sclerosis

(2010) E. MIX et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

A mouse knockout library for secreted and transmembrane proteins

(2010) Tracy Tang et al.   NATURE BIOTECHNOLOGY

Epithelial V-like antigen regulates permeability of the blood–CSF barrier

(2008) Gouri Chatterjee et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

B cells and multiple sclerosis

(2008) Diego Franciotta et al.   LANCET NEUROLOGY